Bridger Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.01M Buy
5,845
+1,109
+23% +$1.13M 4.67% 6
2026
Q1
$4.36M Buy
+4,736
New +$4.8M 3.4% 14
2025
Q3
Sell
-7,307
Closed -$5.7M 29
2025
Q2
$5.7M Buy
+7,307
New +$5.68M 3.36% 15
2024
Q3
Sell
-24,712
Closed -$22.4M 32
2024
Q2
$22.4M Sell
24,712
-3,364
-12% -$2.69M 11.51% 1
2024
Q1
$21.8M Hold
28,076
9.85% 2
2023
Q4
$16.4M Hold
28,076
6.27% 6
2023
Q3
$15.1M Hold
28,076
5.53% 7
2023
Q2
$13.2M Buy
+28,076
New +$11.8M 4.37% 11
2015
Q3
Sell
-349,591
Closed -$29.2M 44
2015
Q2
$29.2M Sell
349,591
-17,302
-5% -$1.32M 0.92% 31
2015
Q1
$26.7M Buy
+366,893
New +$26.1M 1.78% 23
2014
Q2
Sell
-805,000
Closed -$47.4M 42
2014
Q1
$47.4M Buy
+805,000
New +$44.9M 3.16% 13

Other funds holding LLY

Bridger Management's LLY Position: Q2 2026 in Review

Bridger Management increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $1.13M and bringing the position to 5,845 shares worth $7.01M. The position accounts for 4.67% of the portfolio, ranked #6.

Bridger Management first reported a position in LLY in Q1 2014 and has held it in 11 quarters since. The position peaked at $47.4M in Q1 2014. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bridger Management held 5,845 shares of Eli Lilly worth $7.01M as of Q2 2026.
  • Bridger Management bought 1,109 Eli Lilly shares in Q2 2026, an estimated $1.13M.
  • Eli Lilly made up 4.67% of Bridger Management's portfolio in Q2 2026, its #6 holding.
  • Bridger Management first reported a position in Eli Lilly in Q1 2014 and has held it in 11 quarters since.
  • Bridger Management's Eli Lilly position peaked at $47.4M in Q1 2014.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bridger Management's 13F filing for Q2 2026, filed 18 Aug 2026.